|
1
|
Aini S, Bolati S, Ding W, Liu S, Su P,
Aili S, Naman Y and Xuekelaiti K: LncRNA LncRNA SNHG10 suppresses
the development of doxorubicin resistance by downregulating
miR-302b in triple-negative breast cancer. Bioengineered.
13:11430–11439. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alves MT, da Conceição IMCA, de Oliveira
AN, Oliveira HHM, Soares CE, de Paula Sabino A, Silva LM, Simões R,
Luizon MR and Gomes KB: microRNA miR-133a as a biomarker for
Doxorubicin-Induced cardiotoxicity in women with breast cancer: A
signaling pathway investigation. Cardiovasc Toxicol. 22:655–662.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Azadeh M, Salehzadeh A, Ghaedi K and
Talesh Sasani S: NEAT1 can be a diagnostic biomarker in the breast
cancer and gastric cancer patients by targeting XIST, hsa-miR-612
and MTRNR2L8: Integrated RNA targetome interaction and experimental
expression analysis. Genes Environ. 44:162022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cantini L, Bertoli G, Cava C, Dubois T,
Zinovyev A, Caselle M, Castiglioni I, Barillot E and Martignetti L:
Identification of microRNA clusters cooperatively acting on
epithelial to mesenchymal transition in triple negative breast
cancer. Nucleic Acids Res. 47:2205–2215. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen WH, Luo GF, Sohn YS, Nechushtai R and
Willner I: miRNA-specific unlocking of drug-loaded metal-organic
framework nanoparticles: Targeted cytotoxicity toward cancer cells.
Small. 15:e19009352019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Di Cosimo S, Appierto V, Pizzamiglio S,
Tiberio P, Iorio MV, Hilbers F, de Azambuja E, de la Peña L,
Izquierdo M, Huober J, et al: Plasma miRNA levels for predicting
therapeutic response to neoadjuvant treatment in HER2-positive
breast cancer: Results from the NeoALTTO trial. Clin Cancer Res.
25:3887–3895. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hajivalili M, Baghaei K, Mosaffa N, Niknam
B and Amani D: Engineering tumor-derived small extra cellular
vesicles to encapsulate miR-34a, effectively inhibits 4T1 cell
proliferation, migration and gene expression. Med Oncol. 39:932022.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He C, Wang M, Sun X, Zhu Y, Zhou X, Xiao
S, Zhang Q, Liu F, Yu Y, Liang H and Zou G: Integrating PDA
microtube waveguide system with heterogeneous CHA amplification
strategy towards superior sensitive detection of miRNA. Biosens
Bioelectron. 129:50–57. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang R, Yang Z, Liu Q, Liu B, Ding X and
Wang Z: CircRNA DDX21 acts as a prognostic factor and sponge of
miR-1264/QKI axis to weaken the progression of triple-negative
breast cancer. Clin Transl Med. 12:e7682022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang W, Wu X, Xiang S, Qiao M, Cen X, Pan
X, Huang X and Zhao Z: Regulatory mechanism of miR-20a-5p
expression in cancer. Cell Death Discov. 8:2622022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iranparast S, Tahmasebi-Birgani M,
Motamedfar A, Amari A and Ghafourian M: Altered expression levels
of MicroRNA-155 and SOCS-1 in peripheral blood mononuclear cells of
newly diagnosed breast cancer patients. Iran J Allergy Asthma
Immunol. 21:12–19. 2022.PubMed/NCBI
|
|
12
|
Jahangiri L and Ishola T: Dormancy in
breast cancer, the role of autophagy, lncRNAs, miRNAs and exosomes.
Int J Mol Sci. 23:52712022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee JU, Kim WH, Lee HS, Park KH and Sim
SJ: Quantitative and specific detection of exosomal miRNAs for
accurate diagnosis of breast cancer using a Surface-Enhanced raman
scattering sensor based on Plasmonic Head-Flocked gold Nanopillars.
Small. 15:e18049682019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Gao X, Zhang Z, Lai Y, Lin X, Lin B,
Ma M, Liang X, Li X, Lv W, et al: CircCD44 plays oncogenic roles in
triple-negative breast cancer by modulating the miR-502-5p/KRAS and
IGF2BP2/Myc axes. Mol Cancer. 20:1382021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Z, Spoelstra NS, Sikora MJ, Sams SB,
Elias A, Richer JK, Lee AV and Oesterreich S: Mutual exclusivity of
ESR1 and TP53 mutations in endocrine resistant metastatic breast
cancer. NPJ Breast Cancer. 8:622022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lukianova N, Zadvornyi T, Kashuba E,
Borikun T, Mushii О and Chekhun F: Expression of markers of bone
tissue remodeling in breast cancer and prostate cancer cells in
vitro. Exp Oncol. 44:39–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin Z, Wang W, Qu G, Wang L, Wang X and
Pan Q: MiRNA-96-5p impacts the progression of breast cancer through
targeting FOXO3. Thorac Cancer. 11:956–963. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng D, Fu M, Wang M, Wei Y and Wei X:
Targeting TGF-β signal transduction for fibrosis and cancer
therapy. Mol Cancer. 21:1042022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi X, Yang J, Deng S, Xu H, Wu D, Zeng Q,
Wang S, Hu T, Wu F and Zhou H: TGF-β signaling in the tumor
metabolic microenvironment and targeted therapies. J Hematol Oncol.
15:1352022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Richard V, Davey MG, Annuk H, Miller N and
Kerin MJ: The double agents in liquid biopsy: Promoter and
informant biomarkers of early metastases in breast cancer. Mol
Cancer. 21:952022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
San A, Palmieri D, Saxena A and Singh S:
In silico study predicts a key role of RNA-binding domains 3 and 4
in nucleolin-miRNA interactions. Proteins. 90:1837–1850. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sirkisoon SR, Wong GL, Aguayo NR, Doheny
DL, Zhu D, Regua AT, Arrigo A, Manore SG, Wagner C, Thomas A, et
al: Breast cancer extracellular vesicles-derived miR-1290 activates
astrocytes in the brain metastatic microenvironment via the
FOXA2→CNTF axis to promote progression of brain metastases. Cancer
Lett. 540:2157262022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Søiland H, Janssen EAM, Helland T,
Eliassen FM, Hagland M, Nordgård O, Lunde S, Lende TH, Sagen JV,
Tjensvoll K, et al: Liquid biopsies and patient-reported outcome
measures for integrative monitoring of patients with early-stage
breast cancer: A study protocol for the longitudinal observational
prospective breast cancer biobanking (PBCB) study. BMJ OPen.
12:e0544042022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Storci G, De Carolis S, Papi A, Bacalini
MG, Gensous N, Marasco E, Tesei A, Fabbri F, Arienti C, Zanoni M,
et al: Genomic stability, anti-inflammatory phenotype and
up-regulation of the RNAseH2 in cells from centenarians. Cell Death
Differ. 26:1845–1858. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang J..Li Y, Zou Y, Zhao Z, Jiao L and
Zhang H: miR-96-5p induces orbital fibroblasts differentiation by
targeting Smad7 and promotes the development of thyroid-associated
ophthalmopathy. Evid Based Complement Alternat Med. Feb 27;8550307.
2022. View Article : Google Scholar
|
|
26
|
Chao L, Hua-Yu Z, Wen-Dong B, Mei S, Bin
X, Da-Hai H and Yi L: miR-96 promotes collagen deposition in
keloids by targeting Smad7. Exp Ther Med. 17:773–781.
2019.PubMed/NCBI
|
|
27
|
Shi Y, Zhao Y, Shao N, Ye R, Lin Y, Zhang
N, Li W, Zhang Y and Wang S: Overexpression of microRNA-96-5p
inhibits autophagy and apoptosis and enhances the proliferation,
migration and invasiveness of human breast cancer cells. Oncol
Lett. 13:4402–4412. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Uehiro N, Horii R, Iwase T, Tanabe M,
Sakai T, Morizono H, Kimura K, Iijima K, Miyagi Y, Nishimura S, et
al: Validation study of the UICC TNM classification of malignant
tumors, seventh edition, in breast cancer. Breast Cancer.
21:748–753. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Farstad W: Ethics in animal breeding.
Reprod Domest Anim. 53 (Suppl 3):S4–S13. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Percie du Sert N, Hurst V, Ahluwalia A,
Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl
U, et al: The ARRIVE guidelines 2.0: Updated guidelines for
reporting animal research. PLoS Biol. 18:e30004102020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tan L, Mai D, Zhang B, Jiang X, Zhang J,
Bai R, Ye Y, Li M, Pan L, Su J, et al: PIWI-interacting RNA-36712
restrains breast cancer progression and chemoresistance by
interaction with SEPW1 pseudogene SEPW1P RNA. Mol Cancer. 18:92019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang H, Huang X, Wang J, Yang L, Kong Y,
Gao G, Zhang L, Chen ZS and Xie X: circKIF4A acts as a prognostic
factor and mediator to regulate the progression of triple-negative
breast cancer. Mol Cancer. 18:232019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Barzaman K, Karami J, Zarei Z,
Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, Safari E and
Farahmand L: Breast cancer: Biology, biomarkers, and treatments.
Int Immunopharmacol. 84:1065352020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bahreini F, Rayzan E and Rezaei N:
microRNA-related single-nucleotide polymorphisms and breast cancer.
J Cell Physiol. 236:1593–1605. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Y and Li C: lncRNA GHET1 promotes the
progression of Triple-Negative breast cancer via regulation of
miR-377-3p/GRSF1 signaling axis. Comput Math Methods Med.
2022:83665692022.PubMed/NCBI
|
|
37
|
Weng YS, Tseng HY, Chen YA, Shen PC, Al
Haq AT, Chen LM, Tung YC and Hsu HL: MCT-1/miR-34a/IL-6/IL-6R
signaling axis promotes EMT progression, cancer stemness and M2
macrophage polarization in triple-negative breast cancer. Mol
Cancer. 18:422019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu B, Zhang J and Yang D: miR-96-5p
promotes the proliferation and migration of ovarian cancer cells by
suppressing Caveolae1. J Ovarian Res. 12:572019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou J, Sun X, Zhang X, Yang H, Jiang Z,
Luo Q, Liu Y and Wang G: miR-107 is involved in the regulation of
NEDD9-mediated invasion and metastasis in breast cancer. BMC
Cancer. 22:5332022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou Y, Cai W and Lu H: Overexpression of
microRNA-145 enhanced docetaxel sensitivity in breast cancer cells
via inactivation of protein kinase B gamma-mediated
phosphoinositide 3-kinase-protein kinase B pathway. Bioengineered.
13:11310–11320. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yan W, Cao M, Ruan X, Jiang L, Lee S,
Lemanek A, Ghassemian M, Pizzo DP, Wan Y, Qiao Y, et al:
Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote
skeletal muscle proteolysis. Nat Cell Biol. 24:793–804. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang R, Xing L, Zheng X, Sun Y, Wang X and
Chen J: The circRNA circAGFG1 acts as a sponge of
miR-195-5p to promote triple-negative breast cancer progression
through regulating CCNE1 expression. Mol Cancer. 18:42019.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Arase M, Horiguchi K, Ehata S, Morikawa M,
Tsutsumi S, Aburatani H, Miyazono K and Koinuma D: Transforming
growth factor-β-induced lncRNA-Smad7 inhibits apoptosis of mouse
breast cancer JygMC(A) cells. Cancer Sci. 105:974–982. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kong X, Yan K, Deng P, Fu H, Sun H, Huang
W, Jiang S, Dai J, Zhang QC, Liu JG and Xi Q: LncRNA-Smad7 mediates
cross-talk between Nodal/TGF-β and BMP signaling to regulate cell
fate determination of pluripotent and multipotent cells. Nucleic
Acids Res. 50:10526–10543. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gao X, Cao Y, Yang W, Duan C, Aronson JF,
Rastellini C, Chao C, Hellmich MR and Ko TC: BMP2 inhibits
TGF-β-induced pancreatic stellate cell activation and extracellular
matrix formation. Am J Physiol Gastrointest Liver Physiol.
304:G804–G813. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tang PC, Zhang YY, Li JS, Chan MK, Chen J,
Tang Y, Zhou Y, Zhang D, Leung KT, To KF, et al: LncRNA-Dependent
mechanisms of transforming growth Factor-β: From tissue fibrosis to
cancer progression. Noncoding RNA. 8:362022.PubMed/NCBI
|
|
47
|
Luo L, Li N, Lv N and Huang D: SMAD7: A
timer of tumor progression targeting TGF-β signaling. Tumour Biol.
35:8379–8385. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhong C, Xie Z, Shen J, Jia Y and Duan S:
LINC00665: An emerging biomarker for cancer diagnostics and
therapeutics. Cells. 11:15402022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qin WY, Feng SC, Sun YQ and Jiang GQ:
MiR-96-5p promotes breast cancer migration by activating MEK/ERK
signaling. J Gene Med. 22:e31882020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Luo X, Zhang D, Xie J, Su Q, He X, Bai R,
Gao G and Pan W: MicroRNA-96 promotes schistosomiasis hepatic
fibrosis in mice by suppressing smad7. Mol Ther Methods Clin Dev.
11:73–82. 2018. View Article : Google Scholar : PubMed/NCBI
|
